Vertebrate embryos as tools for anti-angiogenic drug screening and function.
Reprod Toxicol
; 70: 49-59, 2017 06.
Article
in En
| MEDLINE
| ID: mdl-27888069
The development of new angiogenic inhibitors highlights a need for robust screening assays that adequately capture the complexity of vessel formation, and allow for the quantitative evaluation of the teratogenicity of new anti-angiogenic agents. This review discusses the use of screening assays in vertebrate embryos, specifically focusing upon chicken and zebrafish embryos, for the detection of anti-angiogenic agents.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Neovascularization, Physiologic
/
Angiogenesis Inhibitors
/
Drug Evaluation, Preclinical
/
Embryo, Mammalian
/
Embryo, Nonmammalian
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
Reprod Toxicol
Year:
2017
Type:
Article